Veronica van Nederveen

Veronica van Nederveen

The complete DNA test provides a complete overview of all potential targeted cancer treatments. The patient and the attending physician have all available information to make a treatment decision.

Back to news

More news

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

11-08-2022

Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …

Comprehensive molecular diagnostics closer for more patients thanks to price reduction 

Comprehensive molecular diagnostics closer for more patients thanks to price reduction 

20-01-2026

Hartwig Medical Foundation reduces the price of its OncoAct Whole Genome Sequencing (WGS) service as of January 1, 2026. This …

New study using Hartwig Medical Foundation data maps how breast cancer’s genetic makeup shifts when it spreads

New study using Hartwig Medical Foundation data maps how breast cancer’s genetic makeup shifts when it spreads

16-07-2026

Analysis of nearly 1,300 tumor genomes across ten genomic subtypes points to candidate drug targets and biomarkers for metastatic breast …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl